Cancer Care Ontario | Cancer Care Ontario

322 Results

Guidelines and Advice

Referral of Suspected Lung Cancer by Primary Care Practitioners

Status: Current
ID: 24-2
Version: 2

Jan 2019

Guidelines and Advice

Neoadjuvant or Adjuvant Therapy for Resectable Gastric Cancer

Status: Archived
ID: 2-14
Version: 3

Apr 2011

Guidelines and Advice

Risk Reduction of Prostate Cancer with Drugs or Nutritional Supplements

Status: Education and Information
ID: 3-3

May 2012

Guidelines and Advice

Systemic Therapy for Advanced or Recurrent Endometrial Cancer and Advanced or Recurrent Uterine Papillary Serous Carcinoma

Status: In-Review
ID: 4-8
Version: 4

Jul 2019

Guidelines and Advice

Optimal Therapy for Patients Diagnosed with Multiple Myeloma and the Role of High-Dose Chemotherapy and Stem Cell Support

Status: Education and Information
ID: 6-6 Version 2
Version: 2

Jan 2012

Guidelines and Advice

Dasatinib for the Treatment of Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

Status: Archived
ID: 6-23 (CED)

Jan 2012

Guidelines and Advice

Pemetrexed Monotherapy for the Maintenance Treatment of Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Non-Squamous Histology

Status: Archived
ID: CED 21

Jan 2011

Guidelines and Advice

Temozolomide Monotherapy for the Treatment of Patients with Glioblastoma that has Relapsed or Progressed Following Prior Therapy

Status: Archived
ID: CED 20

Mar 2011

Guidelines and Advice

The Role of Aromatase Inhibitors in Adjuvant Therapy for Postmenopausal Women with Hormone Receptor-positive Breast Cancer

Status: Archived
ID: 1-18

May 2012

Guidelines and Advice

The Role of Taxanes in Neoadjuvant Chemotherapy for Women with Non-metastatic Breast Cancer

Status: Archived
ID: 1-20
Version: 2

Oct 2011

Guidelines and Advice

18-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer

Status: Current
ID: 7-20 Version 2
Version: 2

Oct 2012

Guidelines and Advice

Breast Irradiation in Women with Early Stage Invasive Breast Cancer Following Breast Conserving Surgery

Status: Education and Information
ID: 1-2
Version: 2

Sep 2011

Referral of Suspected Lung Cancer by Primary Care Practitioners

Neoadjuvant or Adjuvant Therapy for Resectable Gastric Cancer

Risk Reduction of Prostate Cancer with Drugs or Nutritional Supplements

Systemic Therapy for Advanced or Recurrent Endometrial Cancer and Advanced or Recurrent Uterine Papillary Serous Carcinoma

Optimal Therapy for Patients Diagnosed with Multiple Myeloma and the Role of High-Dose Chemotherapy and Stem Cell Support

Dasatinib for the Treatment of Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

Pemetrexed Monotherapy for the Maintenance Treatment of Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Non-Squamous Histology

Temozolomide Monotherapy for the Treatment of Patients with Glioblastoma that has Relapsed or Progressed Following Prior Therapy

The Role of Aromatase Inhibitors in Adjuvant Therapy for Postmenopausal Women with Hormone Receptor-positive Breast Cancer

The Role of Taxanes in Neoadjuvant Chemotherapy for Women with Non-metastatic Breast Cancer

18-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer

Breast Irradiation in Women with Early Stage Invasive Breast Cancer Following Breast Conserving Surgery

Pages